3Harris E N, Gharavi A E, Hughes G R. Anti-phospholipid antibodies [J] . Clin Rheum Dis, 1985, 11 (3): 591-609.
4Wilson W A, Gharavi A E, Koike T, et al. International consensus statement on preliminary classification criteria for definite an tiphospholipid syndrome: report of an international workshop [J] . Arthritis Rheum, 1999, 42 (7) : 1309-1311.
5Miyakis S, Lockshin M D, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite an tiphospholipid syndrome [J] .J Thromb Haemost, 2006, 4 (2): 295-306.
4Kuruvilla A . Warfarin in antiphospholipid antibody syndrome.Lancet, 2001,27(358) : 1461-1462.
5Jilma B, Kamath S, Lip GY. ABC of antithrombotic therapy : an -tithrombotic therapy in special circtanstances. Ⅱ -In children, thrombophilia, and miscellaneous conditions. BMJ, 2003,326: 93-96.
6Vinatier D, Dufour P, Cosson M, et al. Antiphospholipid syndrome and recurrent miscarriages. Eur J Obstet Gynecol Reprod Biol,2001,96: 37- 50.
7Triolo G, Ferrante A, Ciccia F, et al. Randomized study of subcutaneous low molecular weight heparin plus aspirin versus imravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies. Arthritis Rheum, 2003, 48: 728-731.
